Recently, media reports claimed that SinoPharm Health had disbanded its ‘Huimin Bao’ (People’s Benefit Insurance) team, drawing market attention. In response, SinoPharm Health quickly clarified that these rumors are unfounded. The company stated that Huimin Bao—one of its key initiatives in inclusive insurance—remains fully operational, with no team disbandment or business downsizing. SinoPharm Health emphasized its ongoing commitment to enhancing the efficiency and user experience of city-customized commercial medical insurance (commonly known as ‘Huimin Bao’) through technology enablement and data-driven approaches. Currently, the company continues to collaborate with local governments and insurers to optimize and expand Huimin Bao programs. Any personnel adjustments in specific regions are due to normal project cycle changes or partner realignments, representing routine operational refinements rather than a strategic retreat. SinoPharm Health reaffirmed its long-term confidence in the inclusive health insurance sector and pledged continued investment to drive high-quality growth in this business.
近日，有媒体报道称思派健康已解散其‘惠民保’业务团队，引发市场关注。对此，思派健康迅速作出回应，澄清相关传闻并不属实。公司表示，‘惠民保’作为其重点布局的普惠保险产品之一，仍在正常运营中，并未进行团队解散或业务收缩。思派健康强调，公司始终致力于通过科技赋能与数据驱动，提升城市定制型商业医疗保险（即‘惠民保’）的服务效率与用户体验。当前，思派健康正与多地政府及保险公司合作，持续推进惠民保项目的优化与落地。针对个别地区因项目周期调整或合作方变动导致的人员优化，属于正常业务动态调整范畴，并非整体战略撤退。公司重申对普惠健康保险赛道的长期看好，并将继续投入资源推动该业务高质量发展。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/5659.html